Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRC 17536 in Painful Diabetic Neuropathy
NCT01556152Phase 2Withdrawn
- Sponsor
- Glenmark Pharmaceuticals
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of GRC-17536 in diabetic neuropathy, sponsored by Glenmark Pharmaceuticals. Status: withdrawn.
02
Drugs
GRC-17536
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT01556152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01556152.